Mechanism-Guided Design and Synthesis of a Mitochondria-Targeting Artemisinin Analogue with Enhanced Anticancer Activity
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim..
Understanding the mechanism of action (MOA) of bioactive natural products will guide endeavor to improve their cellular activities. Artemisinin and its derivatives inhibit cancer cell proliferation, yet with much lower efficiencies than their roles in killing malaria parasites. To improve their efficacies on cancer cells, we studied the MOA of artemisinin using chemical proteomics and found that free heme could directly activate artemisinin. We then designed and synthesized a derivative, ART-TPP, which is capable of targeting the drug to mitochondria where free heme is synthesized. Remarkably, ART-TPP exerted more potent inhibition than its parent compound to cancer cells. A clickable probe ART-TPP-Alk was also employed to confirm that the attachment of the TPP group could label more mitochondrial proteins than that for the ART derivative without TPP (AP1). This work shows the importance of MOA study, which enables us to optimize the design of natural drug analogues to improve their biological activities.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
---|---|
Enthalten in: |
Angewandte Chemie (International ed. in English) - 55(2016), 44 vom: 24. Okt., Seite 13770-13774 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Chong-Jing [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 28.08.2018 Date Revised 15.09.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/anie.201607303 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM265049695 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM265049695 | ||
003 | DE-627 | ||
005 | 20231224211432.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/anie.201607303 |2 doi | |
028 | 5 | 2 | |a pubmed24n0883.xml |
035 | |a (DE-627)NLM265049695 | ||
035 | |a (NLM)27709833 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Chong-Jing |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mechanism-Guided Design and Synthesis of a Mitochondria-Targeting Artemisinin Analogue with Enhanced Anticancer Activity |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.08.2018 | ||
500 | |a Date Revised 15.09.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. | ||
520 | |a Understanding the mechanism of action (MOA) of bioactive natural products will guide endeavor to improve their cellular activities. Artemisinin and its derivatives inhibit cancer cell proliferation, yet with much lower efficiencies than their roles in killing malaria parasites. To improve their efficacies on cancer cells, we studied the MOA of artemisinin using chemical proteomics and found that free heme could directly activate artemisinin. We then designed and synthesized a derivative, ART-TPP, which is capable of targeting the drug to mitochondria where free heme is synthesized. Remarkably, ART-TPP exerted more potent inhibition than its parent compound to cancer cells. A clickable probe ART-TPP-Alk was also employed to confirm that the attachment of the TPP group could label more mitochondrial proteins than that for the ART derivative without TPP (AP1). This work shows the importance of MOA study, which enables us to optimize the design of natural drug analogues to improve their biological activities | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a anticancer activity | |
650 | 4 | |a drug delivery | |
650 | 4 | |a fluorescent probe | |
650 | 4 | |a mitochondria targeting | |
650 | 4 | |a triphenylphosphonium | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Artemisinins |2 NLM | |
650 | 7 | |a artemisinin |2 NLM | |
650 | 7 | |a 9RMU91N5K2 |2 NLM | |
700 | 1 | |a Wang, Jigang |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jianbin |e verfasserin |4 aut | |
700 | 1 | |a Lee, Yew Mun |e verfasserin |4 aut | |
700 | 1 | |a Feng, Guangxue |e verfasserin |4 aut | |
700 | 1 | |a Lim, Teck Kwang |e verfasserin |4 aut | |
700 | 1 | |a Shen, Han-Ming |e verfasserin |4 aut | |
700 | 1 | |a Lin, Qingsong |e verfasserin |4 aut | |
700 | 1 | |a Liu, Bin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Angewandte Chemie (International ed. in English) |d 1964 |g 55(2016), 44 vom: 24. Okt., Seite 13770-13774 |w (DE-627)NLM000105422 |x 1521-3773 |7 nnns |
773 | 1 | 8 | |g volume:55 |g year:2016 |g number:44 |g day:24 |g month:10 |g pages:13770-13774 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/anie.201607303 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 55 |j 2016 |e 44 |b 24 |c 10 |h 13770-13774 |